Bromodomain Containing 7 (BRD7) Peptid
Kurzübersicht für Bromodomain Containing 7 (BRD7) Peptid (ABIN939729)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KELAQQVTPG DIVSTYGVRK AMGISIPSPV MENNFVDLTE DTEEPKKTDV
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BRD7 antibody,
Alternative Names: BRD7 control peptide, BRD7 antibody Blocking Peptide, Anti-BRD7 Blocking Peptide, bromodomain containing 7 Blocking Peptide, BP75 Blocking Peptide, CELTIX1 Blocking Peptide, NAG4 Blocking Peptide, BRD7, BRD-7, BRD 7, BRD-7 Blocking Peptide, BRD 7 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Hintergrund
- BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.
-
Molekulargewicht
- 74 kDa
Target
-